Balancing risks with JAK inhibitors in RMDs after the ORAL Surveillance study
1 track • 0 play • 0 paborito
Balancing risks with JAK inhibitors in RMDs after the ORAL Surveillance study
user4304645171849
0:0017:09
News
Mga Episode
1
Balancing risks with JAK inhibitors in RMDs after the ORAL Surveillance study
user4304645171849